QDMClass II

Midazolam Syringe

21 CFR 880.5860 / General Hospital

QDM is the FDA product code for Midazolam Syringe, a class II device type, regulated under 21 CFR 880.5860. FDA's definition for this code reads: "Intended for intramuscular injection of midazolam". As of 2026-09-10, FDA records hold no 510(k) clearances under this code and no recalls.

Classification record

Product code: QDM
Device name: Midazolam Syringe
FDA definition: Intended for intramuscular injection of midazolam.
Regulation: 21 CFR 880.5860
Device class: Class II
Review panel: General Hospital
Submission type: 510(k)
Implant: No
Life sustaining or supporting: No
GMP exempt: No
Third party review eligible: No
Ingested clearances: 0
Ingested recalls: 0

Companies listing this code with FDA

Companies whose registered establishments list this code

No registered establishment in MDM’s records lists product code QDM.

Recent clearances

Product code QDM

FDA records hold no clearances under product code QDM.

Recent recalls

Product code QDM

FDA records show no recalls under product code QDM.

MDM coverage of this record lists here, newest first.

About this record

Sourced from the FDA device classification database, ingested from openFDA. The definition, regulation number, device class and review panel are FDA’s own fields, reproduced without editing.

MDM adds the counts: clearances by decision year, the applicants holding the most clearances under this code, recalls that name it, and the registered establishments that list it. Every count is computed from ingested records only.

Data as of 2026-10-05, the FDA export date for this dataset. Page last changed 2026-09-05. View this product code on fda.gov (opens on fda.gov)